Journal News

Elusive zebrafish enzyme in lipid secretion

Isabel Casas Emily Ulrich
May 1, 2025

Lipids provide energy and structural components during vertebrate development. Lipoproteins aid in lipid transport throughout the body, and synthesized lipids are also stored in lipid droplets within the cell. Embryos of the model organism zebrafish receive nutrients, including lipids, from a maternally deposited yolk through extraembryonic tissue called the yolk syncytial layer, or YSL. Lipid nutrients are released through the production and secretion of lipoproteins rich in triacylglycerol, or TAG. Scientists want to understand which enzymes direct TAG production to lipoproteins for secretion versus lipid droplets for storage.

In a recent Journal of Biological Chemistry article, Meredith Wilson from Johns Hopkins University and U.S. and U.K. colleagues investigated the fate of TAG in zebrafish lacking certain TAG synthesis enzymes. They found that zebrafish lacking diacylglycerol acyltransferase-2, or Dgat2, can still produce TAG, but the TAG is channeled for YSL storage instead of secretion, as noted by the excessive accumulation of lipid droplets in the YSL that make it look opaque.

The authors concluded that zebrafish have multiple enzymes to ensure TAG production remains intact. Future studies will identify the enzyme that fails to properly channel TAG to lipoprotein formation for secretion in embryonic development.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Isabel Casas

Isabel Casas is the ASBMB’s publications director.

Emily Ulrich

Emily Ulrich is ASBMB’s former science editor.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Unraveling the language of histones
Profile

Unraveling the language of histones

Nov. 20, 2025

Philip Cole presented his research on how posttranslational modifications to histones are involved in gene expression and how these modifications could be therapeutically targeted to treat diseases like cancer.

How Alixorexton could transform narcolepsy treatment
News

How Alixorexton could transform narcolepsy treatment

Nov. 18, 2025

A new investigational drug, alixorexton, targets the brain’s orexin system to restore wakefulness in people with narcolepsy type 1. Alkermes chemist Brian Raymer shares how molecular modeling turned a lab idea into a promising phase 3 therapy.

Phosphatases and pupils: A dual legacy
Profile

Phosphatases and pupils: A dual legacy

Nov. 13, 2025

Yale professor Anton Bennett explores how protein tyrosine phosphatases shape disease, while building a legacy of mentorship that expands opportunity and fuels discovery in biochemistry and molecular biology.

Extracellular vesicles offer clues to cattle reproduction
Journal News

Extracellular vesicles offer clues to cattle reproduction

Nov. 11, 2025

Extracellular vesicles from pregnant cattle support embryo development better than laboratory models, highlighting their potential to improve reproductive efficiency in bovine embryo cultures. Read more about this recent MCP paper.

Proteomics reveals protein shifts in diabetic eye disease
Journal News

Proteomics reveals protein shifts in diabetic eye disease

Nov. 11, 2025

Using proteomics, researchers identified protein changes in eye fluid that mark diabetic retinopathy progression and may serve as biomarkers for vision-threatening complications. Read more about this recent MCP paper.

Protein modifications drive lung cancer resistance
Journal News

Protein modifications drive lung cancer resistance

Nov. 6, 2025

New assay enriches protein modifications in a single process, enabling detection of key changes in drug-resistant lung cancer cells that may guide future therapies.